NCT06601049

Effectiveness of ResArgin on Adult's Body Composition and Health

Effectiveness of ResArgin on Adult's Body Composition and Health: a Randomized Double-Blind Placebo-Controlled Trial

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Dr. Heather Hausenblaus · Academic / Other
• Sex: All
• Age: 25 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to learn if the supplement ResArgin (a reservatrol-based supplement) works to slow down muscle loss during a period of fat loss. Other related health outcomes such as sleep, mood, and activity will be assessed. The main questions it aims to answer are: Does ResArgin improve muscle loss? Does ResArgin improve sleep quality, activity, mood, and body satisfaction. Researchers will compare ResArgin to a placebo (a look-alike substance that contains no active ingredients) to see if ResArgin works to improve muscle loss and related health outcomes. Participants will: Take ResArgin or the Placebo every day for 3 months Assessment will occur at Baseline, Day 30, Day 60, and Day 90. Participants will complete a daily diary of their mood and health.

Detailed description

Study Purpose: Examine the effectiveness of ResArgin in attenuating muscle loss during a period of fat loss in overweight and mildly obese men and women. Outcomes: Primary outcomes will be body composition. Secondary outcomes will be physical activity, food cravings, health-related quality of life, body satisfaction, basal metabolic rate, sleep behaviors, mood, anxiety, and perceived stress. Study Design • Randomized double-blind placebo-controlled trial o N = 60 men and women (30 adults in the ResArgin Condition and 30 adults in the Placebo Condition).

Conditions

• Weight Loss

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	ResArgin	Resveratrol-based supplement

Timeline

• Start date: 2024-08-15
• Primary completion: 2024-11-15
• Completion: 2025-02-15
• First posted: 2024-09-19
• Last updated: 2024-09-19

Locations

1 site across 1 country: United States